Company Filing History:
7 out of 17 
5 out of 28 
4 out of 541 
Years Active: 2000-2020
Title: Alison Jane Wilton: A Trailblazing Inventor in the Field of Biotechnology
Introduction:
Alison Jane Wilton, a dedicated innovator based in Cambridge, GB, has etched her name in the annals of biotechnology with her remarkable contributions and trailblazing spirit. With a total of 20 patents to her name, Alison's relentless pursuit of innovation has positioned her as a leading inventor in the global landscape.
Latest Patents:
Among Alison's latest patents is the groundbreaking work on "Human antibodies against eotaxin and their use." These patents focus on specific binding members directed to eotaxin-1, particularly human antibodies and antibody fragments that neutralize eotaxin-1 activity. The innovations include the antibodies VH and/or VL domain of the scFv fragment termed CAT-212 and the IgG4 antibody CAT 213. These patents also cover methods of obtaining specific binding members that bind eotaxin, paving the way for novel therapeutic approaches.
Career Highlights:
Alison Jane Wilton has made significant strides in her career, with notable stints at Abbott Biotechnology Ltd. and Cambridge Antibody Technology Limited. Her expertise and innovative approach have been instrumental in driving advancements in biotechnology and pharmaceutical research, leading to the development of impactful solutions in the healthcare industry.
Collaborations:
Throughout her career, Alison has collaborated with esteemed professionals in the field, including coworkers Tristan J Vaughan and Jochen G Salfeld. These collaborations have not only enhanced the quality of her work but also fostered a culture of innovation and knowledge-sharing within the scientific community.
Conclusion:
In conclusion, Alison Jane Wilton's dedication to innovation and her pioneering work in biotechnology underscore her status as a trailblazing inventor. Her patents and contributions have not only transformed the way we approach healthcare but also inspired future generations of inventors to push the boundaries of what is possible in the realm of biotechnology. Alison's relentless pursuit of excellence serves as a testament to the power of innovation in driving positive change in our world.